This is what is very much needed. Here we have a medical professional not paid by or linked directly with IMU, Dr Tony DHILLON, from an English hospital publicly excited. This will allow the results to be looked at and scrutinised more publicly, and that sort of exposure will help project Imugene’s name into many more hospitals where it needs to be and should be. Once leading oncologists get talking to each other it will snowball IMO. I know Imugene is known already, but this will help put IMU in neon lights.
Ann: New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS, page-29
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.002(4.65%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.5¢ | 4.3¢ | $732.0K | 16.76M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1799587 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 1003772 | 13 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |